1. Introduction {#sec0005}
===============

Despite the fact that milk and dairy products are considered fundamental constituents of the Mediterranean diet and it is thus suggested that they are to be consumed daily; dairy products have been the subject of controversy regarding their impact on human health. According to the recommendations of the World Health Organization (WHO), consumption of dairy products should be limited in order to minimize the intake of cholesterol and saturated fatty acids (SFA) such as palmitic and myristic acid, in order to reduce the incidences of cardiovascular disease risk globally ([@bib0135]). On the other hand, several clinical studies suggest that the consumption of milk and dairy products may exert a possible protective effect against coronary heart disease, since they contain components such as calcium, magnesium, potassium, vitamin D and certain amino acids ([@bib0025]). Some constituents such as peptides, linoleic acid, conjugated linoleic acid (CLA), antioxidants, lactic acid bacteria and probiotic bacteria present in milk and dairy products have been shown to contribute to the functionality of dairy products against chronic diseases ([@bib0110]). Dairy products also contain polar lipids such as phosphatidylcholine (PC) and sphingomyelin (SM), which are mainly located in the milk fat globule membrane. Evidence suggests that both PC and SM possess strong anti-inflammatory activities and therefore the capacity to attenuate cardiovascular risk ([@bib0050]).

Milk has been found to have moderate cardioprotective properties in comparison to fermented dairy products, especially yogurt. The biologically active peptides derived during bacterial fermentation of milk are thought to have anti-thrombotic properties ([@bib0045]). Moreover, during yogurt fermentation, the bacteria *Streptococcus thermophillus* and *Lactobacillus bulgaricus* seem to enhance the bioformation of lipids capable of inhibiting platelet activation induced by Platelet Activating Factor (PAF) ([@bib0010]). PAF, (1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) is a strong phospholipid intermediary of inflammation ([@bib0035]) and it is regarded as a trigger molecule for the onset of atherogenesis ([@bib0030]). PAF is involved in the inflammatory generation of plaque and the hindrance of blood vessels, which are the main causes of coronary heart diseases ([@bib0030]). Milk and dairy products contain compounds that can inhibit PAF activity, acting as PAF- inhibitors. These dairy components are of particular nutritional merit because they impede platelet aggregation in arteries while at the same time they prevent atheromatosis development ([@bib0010]; [@bib0105]; [@bib0130]).

Recent studies have demonstrated that dairy products may possess cardioprotective and immunomodulatory bioactivities *in vivo*. In one such study, the cardiovascular impact of Minas Frescal cheese consumption was assessed in hypertensive rats. The consumption of this cheese resulted in the significant lowering of blood pressure and an improved lipid profile in the rats ([@bib0055]). Furthermore, another study examined probiotic fermented milk treated by dynamic high pressure, which was fed to rats for 2 weeks. The fermented milk product was effective in reducing the impact of exercise-induced immunosuppression ([@bib0060]).

Greek yogurt is produced from three different kinds of milk namely cow, ewe and goat milk. Generally Greek yogurt production does not standardize or homogenize milk resulting in the formation of a crust on the yogurt's surface ([@bib0115]). Cow yogurt is consumed largely due to its low price and less distinctive smell compared to those derived from other ruminant milk sources. The aim of the current study was to evaluate the fatty acid contents, the *in vitro* anti-thrombotic properties and the sensory characteristics of three different yogurts produced from cow, ewe and goat milk respectively.

2. Materials and methods {#sec0010}
========================

2.1. Reagents and instruments {#sec0015}
-----------------------------

All reagents and solvents along with the silica gel G-60 used for Thin Layer Chromatography (TLC) separation were supplied by Merck (Darmstadt, Germany). Bovine serum albumin (BSA), PAF, the fatty acid methyl ester (FAME) standards and the polar lipid standards used for TLC separation (mix standard of hen egg yolk) were supplied by Sigma-Aldrich (St. Louis, MO, USA). Platelet aggregation was measured using a Chrono-Log (Havertown, PA, USA) aggregometer (model 400-VS) coupled to a Chrono-Log recorder (Havertown, PA, USA).

2.2. Yogurt samples {#sec0020}
-------------------

Three different types of Greek yogurt, i.e. cow, ewe and goat yogurt were purchased from supermarkets in Athens, Greece. The lipid content of cow, ewe and goat yogurt samples were 3.5%, 4.0% and 7.0%, respectively (i.e. g of lipid/100 g food). All samples were sealed in clay pots, transferred to the laboratory and kept at 4C prior to further analysis.

2.3. Isolation of total lipids (TL), total polar lipids (TPL) and total neutral lipids (TNL) {#sec0025}
--------------------------------------------------------------------------------------------

Total lipids (TL) of all yogurt samples were extracted from 100 g of each sample (cow, ewe and goat yogurt) according to the Bligh-Dyer method ([@bib0015]) and separated into total polar lipids (TPL) and total neutral lipids (TNL) by countercurrent distribution ([@bib0040]).

2.4. Fractionation of TPL by preparative Thin Layer Chromatography (TLC) {#sec0030}
------------------------------------------------------------------------

The fractionation of TPL was carried out as described by [@bib0080]. About 45 mg of goat and ewe yogurt TPL were applied to the TLC plates. All isolated lipid fractions obtained were evaporated to dryness under nitrogen; the lipids were weighed and re-dissolved in 1 mL chloroform/methanol 1:1 (v/v) and stored at −20 °C until further analysis.

2.5. Biological assay on washed rabbit platelets {#sec0035}
------------------------------------------------

TL and TPL of the three types of yogurt (i.e. cow, ewe and goat yogurt) and TLC polar lipid fractions of goat and ewe yogurt samples were tested for their *in vitro* biological activity against 2.5 × 10^−11^ M PAF (final concentration in the cuvette) towards washed rabbit platelets. Washed rabbit platelets were prepared as described by [@bib0035]. The EC~50~, namely the 50% maximal effective concentration of aggregation, and IC~50~ the inhibitory concentration for 50% inhibition, values were calculated for each biologically active lipid fraction, as described by [@bib0080].

2.6. Gas chromatographic analysis {#sec0040}
---------------------------------

Fatty acid methyl esters (FAME) of 35 mg of TPL and 35 mg of TNL of all yogurt samples were prepared and analyzed by GC-FID using the internal standard method, as described by [@bib0095]. A five-point calibration curve (given by the equation y = 0.00012x + 0.0167 with r = 0.99993) was prepared using five solutions of heptadecanoic (17:0) acid methyl ester and heneicosanoic (21:0) acid methyl ester in various ratios ([@bib0105]). The ratio of the area of the analyte peak to that of the internal standard represented the y value in the above equation, and subsequently, the x value represents the analyte concentration of the fatty acid in the unknown mixture. This equation was used in order to quantify the analytes. The GC-FID analysis of FAMEs was carried out as described by [@bib0095].

2.7. Sensory evaluation of yogurt samples {#sec0045}
-----------------------------------------

The training of the panelists in order a) to identify and give scores for the attributes taste, flavor, aftertaste and odour and b) to distinguish and give scores for the basic senses of taste namely sweet, salty, bitter and sour was carried out as described by [@bib0120]. The panel consisted of 10 assessors (5 females, 5 males), aged 24--45 years, recruited from the University of Athens. Four dairy products (milk; cheese; buttermilk and Greek feta cheese) were used for training the assessors to different textures. During the seventh successive session, two samples of cow and ewe yogurt, different from the samples used for the analysis in this study, were used as a frame of reference in order to develop terminology based on the attribute differences ([@bib0120]). The evaluation of taste, aftertaste and texture was performed according to a list of fifteen attributes: five for taste (fatty, rich, sour, delicious, whey), five for aftertaste (sweet, pleasant, goaty, intense, persistent), and five for texture (creamy, smooth, velvety, grainy, fluid).

2.8. Statistical analysis {#sec0050}
-------------------------

All experimental analyses were carried out in triplicate, and the obtained results were expressed as mean value ± standard deviation (SD). One-way analysis of variance (ANOVA) was employed in order to find the significant statistical significant differences. When differences were identified at a significant level of *p* \< 0.05 then multiple comparisons of the means were conducted using the Fisher's least significant difference (LSD) test at *p* \< 0.05. Statistical analysis of the data was conducted using the statistical software package PASW 18 for Windows (SPSS Inc., Chicago, 215 IL, USA). For the principal component analysis (PCA), XLSTAT 18.06 (Addinsoft, Paris, France), was used.

3. Results {#sec0055}
==========

3.1. Lipid contents of cow, ewe and goat yogurt samples {#sec0060}
-------------------------------------------------------

The TL, TPL and TNL levels found in cow, ewe and goat yogurt are shown in [Table 1](#tbl0005){ref-type="table"}. Cow and goat yogurts have been found to have similar levels of TL and TNL, whereas in the ewe's yogurt sample, the levels of TL levels were found to be statistically higher. The levels of TPL in cow and ewe yogurts were similar, but goat yogurt contained statistically lower levels of TPL.Table 1Content of total lipids (TL), expressed in grams per 100 g yogurt (mean ± SD, n = 3), total polar lipids (TPL) and total neutral lipids (TNL), expressed as percentages of TL in cow, goat and ewe yogurt samples.Table 1SampleTL (g/100 g yogurt)TPL (% TL)TNL (% TL)Cow3.06 ± 0.92^a^13.4 ± 2.01^a^83.9 ± 5.56^a^Goat3.75 ± 0.90^a^9.45 ± 1.78^b^81.6 ± 5.02^a^Ewe6.76 ± 1.25^b^13.2 ± 2.10^a,b^77.6 ± 4.19^a^[^1]

3.2. Fatty acid profile of TPL and TNL of cow, ewe and goat yogurt samples {#sec0065}
--------------------------------------------------------------------------

The TPL and TNL fatty acid profiles of cow, ewe and goat yogurt are presented in [Table 2](#tbl0010){ref-type="table"} and [Table 3](#tbl0015){ref-type="table"}, respectively. The levels of saturated fatty acids (SFA) were found to be higher in both TPL and TNL of all yogurt samples followed by monounsaturated fatty acids (MUFA) and polyunsaturated fatty acids (PUFA). Both the TPL and TNL of all yogurt samples contain the following fatty acids: caproic (6:0), capric (10:0), lauric (12:0), myristic (14:0), palmitic (16:0), stearic (18:0), oleic (18:1), linoleic (18:2) and a-linolenic (18:3) fatty acid. The most abundant fatty acids in both the TPL and TNL yogurt lipid fractions were palmitic (16:0), stearic (18:0) and oleic (18:1) fatty acids. The TPL fraction of ewe yogurt was found to contain statistically higher levels (*p* \< 0.05) of caproic (6:0), capric (10:0), lauric (12:0), myristic (14:0), palmitic (16:0), stearic (18:0), oleic (18:1) and linoleic (18:2) fatty acids than the TPL fractions of goat and cow yogurts ([Table 2](#tbl0010){ref-type="table"}). The TNL fraction of goat yogurt was found to exhibit statistically higher levels (*p* \< 0.05) of caprylic acid (C8:0), capric (10:0), lauric (12:0), myristic (14:0), palmitic (16:0), oleic (18:1), linoleic (18:2) and α-linolenic (18:3) fatty acids in contrast to the TNL fractions of ewe and cow yogurts ([Table 3](#tbl0015){ref-type="table"}). The rather low levels of fatty acids in the TNL and TPL fractions are in concurrence with similar work on the TPL and TNL of goat dairy products ([@bib0105]).Table 2Fatty acid profile of total polar lipids (TPL) of each sample expressed in milligrams per kilogram of each yogurt sample (mean ± SD, n = 3).Table 2Fatty acidsCow yogurtGoat yogurtEwe yogurt6:022.1 ± 1.99^a^12.4 ± 0.22^b^54.7 ± 5.30^c^8:0ND4.34 ± 0.28^a^5.85 ± 0.27^b^10:03.11 ± 0.16^a^32.2 ± 1.20^b^56.2 ± 4.38^c^12:03.04 ± 0.15^a^14.1 ± 0.52^b^40.9 ± 1.16^c^14:016.3 ± 0.32^a^39.4 ± 0.82^b^126 ± 4.28^c^15:0ND1.00 ± 0.12^a^3.55 ± 0.01^b^16:059.3 ± 0.25^a^142 ± 1.29^b^293 ± 3.12^c^16:1 (ω-7)1.05 ± 0.05^a^2.54 ± 0.21^b^ND18:024.9 ± 0.01^a^69.2 ± 0.59^b^512 ± 9.25^c^18:1 (cis) (ω-9)52.6 ± 0.28^a^173 ± 3.61^b^243 ± 1.89^c^18:2 (cis) (ω-6)12.5 ± 0.03^a^32.5 ± 0.15^b^38.8 ± 0.01^c^18:3 (cis) (ω-3)ND5.21 ± 0.04^a^8.90 ± 0.03^b^20:0ND1.67 ± 0.16^a^4.23 ± 1.10^b^20:1 (ω-9)ND0.29 ± 0.01^a^1.52 ± 0.67^b^20:4ND0.83 ± 0.06ND24:0ND0.83 ± 0.11NDSFA129 ± 0.13^a^317 ± 0.09^b^1096 ± 0.03^c^MUFA53.7 ± 0.05^a^176 ± 0.09^b^245 ± 0.05^c^PUFA12.5 ± 0.05^a^38.5 ± 0.07^b^47.7 ± 0.04^c^[^2]Table 3Fatty acid profile of total neutral lipids (TNL) of each sample expressed in milligrams per kilogram of each yogurt sample (mean ± SD, n = 3).Table 3Fatty acidsCow yogurtGoat yogurtEwe yogurt6:0182 ± 1.99^a^211 ± 6.20^b^340 ± 2.01^c^8:031.8 ± 3.17^a^118 ± 2.77^b^9.46 ± 2.33^c^10:0200 ± 0.24^a^748 ± 7.21^b^198 ± 4.33^c^12:0194 ± 7.48^a^294 ± 0.01^b^138 ± 2.29^c^14:0653 ± 6.56^a^913 ± 4.29^b^457 ± 4.77^c^14:1 (ω-5)31.3 ± 1.03NDND15:062.4 ± 0.86^a^35.0 ± 0.13^b^3.14 ± 0.86^c^16:01959 ± 5.23^a^3009 ± 2.64^b^1422 ± 9.59^c^16:1 (ω-7)85.6 ± 1.05NDND17:1 (ω-7)7.96 ± 0.74NDND18:0665 ± 4.74^a^1917 ± 10.9^b^2575 ± 4.72^c^18:1 (cis) (ω-9)1910 ± 0.27^a^2399 ± 0.12^b^1288 ± 4.52^c^18:2 (cis) (ω-6)207 ± 0.13^a^286 ± 0.71^b^158 ± 0.08^c^18:3 (cis) (ω-3)10.7 ± 0.07^a^62.3 ± 0.18^b^13.8 ± 9.75^c^20:0NDND14.5 ± 0.12SFA3947 ± 0.02^a^7245± 0.07^b^5157 ± 0.08^c^MUFA2035 ± 0.11^a^2399 ± 0.03^b^1288 ± 0.06^c^PUFA218 ± 0.04^a^348 ± 0.03^b^172 ± 0.03^c^[^3]

3.3. *In vitro* anti-thrombotic activity of TL, TPL and TLC polar lipid fractions {#sec0070}
---------------------------------------------------------------------------------

The TL, TPL and TLC polar lipid fractions of all yogurt samples were assessed for their ability to induce washed rabbit platelet aggregation (EC~50~) or inhibit the PAF-induced washed platelet aggregation (IC~50~). The corresponding results for biological activity are expressed in micrograms (μg) for the TL and TPL fractions of all yogurt samples and are presented in [Fig. 1](#fig0005){ref-type="fig"}.Fig. 1*In vitro* biological activities of total lipids (TL) and total polar lipids (TPL) of cow, ewe and goat yogurts towards washed rabbit platelet aggregation, expressed in micrograms of TL and TPL. Washed rabbit platelet concentration was approximately 500,000 platelets μL ^−1^. The final concentration of PAF in the cuvette was 2.5 × 10^−11^ M. The experimental analyses were carried out in triplicate (n = 3).Fig. 1

According to [Fig. 1](#fig0005){ref-type="fig"}, both the TL and TPL fractions of all three yogurt samples have been found to exert inhibitory activity, thus, it could be suggested that these fractions contain lipids that act as PAF inhibitors. The IC~50~ values for the TL and TPL goat yogurt samples (33.0 μg and 15.4 μg, respectively), were found to be significantly lower (*p* \< 0.05) compared to the values for ewe yogurt (43.1 μg and 27.2 μg, respectively) and cow yogurt (45.4 μg and 40.8 μg, respectively) ([Fig. 1](#fig0005){ref-type="fig"}). At this point, it should be emphasized that the lower the IC~50~ value, the stronger the anti-thrombotic potency of the lipid fraction, since less amount of lipid is required to exert 50% inhibition of the PAF-induced washed platelet aggregation. Finally, it should also be stated that the TPL of all three yogurt samples have been found to show stronger inhibitory activity than the TL, within the same yogurt sample ([Fig. 1](#fig0005){ref-type="fig"}); neither the TL nor the TPL of all samples showed any aggregation.

According to [Fig. 1](#fig0005){ref-type="fig"}, the TPL of goat and ewe yogurt have been found to exhibit the strongest *in vitro* anti-thrombotic activity; thus these lipid fractions were selected for further separation by preparative TLC, as shown in [Fig. 2](#fig0010){ref-type="fig"}a and b, respectively. The biological activities of the TLC polar lipid fractions derived from goat and ewe yogurts, expressed in micrograms (μg), are shown in [Fig. 3](#fig0015){ref-type="fig"}a and b, respectively.Fig. 2Typical profile of total polar lipid (TPL) separation on preparative thin-layer chromatography (TLC). a) goat yogurt sample, b) ewe yogurt sample. In the photo, the seven bands obtained are shown on the right whereas on the left, the corresponding elution front of standard compounds is given. L-PC: lyso-phosphatidylcholine, SM: sphingomyelin, PC: phosphatidylcholine, L-PE: lyso-phosphatidylethanolamine, PE: phosphatidylethanolamine, CL: cardiolipin. The preparative plates TLC were stained with iodine vapours.Fig. 2Fig. 3*In vitro* biological activity of preparative thin-layer chromatography (TLC) polar lipid fractions of a) goat yogurt sample and b) ewe yogurt sample, towards washed rabbit platelet aggregation, expressed in micrograms. Washed rabbit platelet concentration was approximately 500,000 platelets μL ^−1^. The final concentration of PAF in the cuvette was 2.5 × 10^−11^ M. The experimental analyses were carried out in triplicate (n = 3).Fig. 3

According to [Fig. 2](#fig0010){ref-type="fig"}a and b, seven bands of polar lipid fractions have been found in both yogurt samples. These results correspond with previously published research on the lipid fractions obtained in goat cheese ([@bib0105]).

All TLC polar lipid fractions of goat and ewe yogurt were found to exhibit inhibitory activity against the actions of PAF (IC~50~ value), while only band 2 of the TLC polar lipid fractions exhibited aggregatory activity (EC~50~ value) ([Fig. 3](#fig0015){ref-type="fig"}a and b). The TLC polar lipid fraction 2 has been found to have a similar R~f~ value corresponding to sphingomyelin (SM). The TLC polar lipid fractions 3 and 7 of the goat yogurt samples exert a greater *in vitro* anti-thrombotic activity in comparison to the respective TLC polar lipid fractions of the ewe yogurt sample (28.4 μg as opposed to 122 μg for fraction 3 and 46.8 μg as opposed to 85.2 μg for fraction 7 ([Fig. 3](#fig0015){ref-type="fig"}a and b). Fractions 3 and 7 correspond to the R~f~ values of phosphatidylcholine (PC) and cardiolipin (CL), respectively.

By comparing the biological activities of the TLC polar lipid fractions of both yogurt samples, it could be said that the TLC polar lipid fractions 3, 4, 5, 6 and 7 of goat yogurt sample have been found to exert statistically lower IC~50~ values (*p* \< 0.05). Therefore, the goat TLC polar lipid fractions possess stronger anti-thrombotic activity in comparison to the activity of the ewe yogurt TLC polar lipid fraction ([Fig. 3](#fig0015){ref-type="fig"}a and b). Conversely, the TLC polar lipid fractions 1 and 2 of the goat yogurt sample have shown statistically higher IC~50~ values (*p* \< 0.05) compared to the ewe yogurt sample ([Fig. 3](#fig0015){ref-type="fig"}a and b). The TLC lipid fraction 3 of both yogurt samples, which has an R~f~ value corresponding to phosphatidylcholine (PC), also exhibited potent *in vitro* anti-thrombotic activity.

3.4. Sensory analysis {#sec0075}
---------------------

The panelists scored the three yogurt samples using values between zero (0, least liked) and ten (10, most liked) for attributes describing the taste, aftertaste and texture properties. The scores of each yogurt sample (cow, ewe or goat yogurt samples) for each attribute used are given in the form of spider-web plots ([Fig. 4](#fig0020){ref-type="fig"}). The sensory data was also subjected to principal component analysis in order to detect if there was a pattern in the sensory data ([@bib0070]).Fig. 4Comparison of sensory profiles of cow, ewe and goat yogurt samples. The scores for a) taste b) aftertaste and c) texture attributes are given as spider-web plots.Fig. 4

The assessors indicated statistically significant organoleptic differences among cow, ewe and goat yogurt. According to [Fig. 4](#fig0020){ref-type="fig"}, the ewe yogurt sample has been found to rate significantly higher for the taste attributes of "fatty", "rich", "delicious", and "whey" and for the texture attribute "'grainy"'. On the other hand, the goat yogurt sample has been found to rate significantly higher for the attribute of "sour" for taste, the attributes of "persistent", "intense", and "goaty" for the aftertaste and the attributes of "velvety", "smooth" and "fluid" for the texture ([Fig. 4](#fig0020){ref-type="fig"}). The cow yogurt samples have been found to rate significantly higher only for the aftertaste attribute of "sweet" ([Fig. 4](#fig0020){ref-type="fig"}). As it is observed from the PCA ([Fig. 5](#fig0025){ref-type="fig"}), the first two factors accounted for 25.25% and 19.09% of the variance respectively. Factor one separated most of the samples B (goat yogurt) from samples A and C (ewe and cow yogurts respectively). The goat yogurt was characterised as goaty, rich, smooth, intense and persistent. However, in the case of F2 the separation was not clear. Despite the fact that only 44.34% of the variance was described using the first two factors, we still gain a useful insight into the positioning of the three yogurts in relation to their sensory characteristics.Fig. 5Principal component analysis (PCA) of the three yogurt samples (A: ewe yogurt, B: goat yogurt, C: cow yogurt).Fig. 5

4. Discussion {#sec0080}
=============

Dairy products have been linked with the increased risk of CVDs, due to their high concentration in SFA and cholesterol ([@bib0065]). However, recent data on the levels of bioactive fatty acids (e.g. short-chain fatty acids and CLA) and other minor components (e.g. phospholipids and sphingolipids) indicate that dairy products may have a positive important impact on cardiovascular and metabolic risk factors ([@bib0020]).

In the current study, it was demonstrated that the TL and TPL fractions of all yogurt samples tested (cow, ewe and goat yogurts) contain PAF inhibitors ([Fig. 1](#fig0005){ref-type="fig"}), which is in accordance with the literature ([@bib0010]; [@bib0105]). The TL and TPL of the goat yogurt samples exhibited the most potent biological activity against PAF ([Fig. 1](#fig0005){ref-type="fig"}), suggesting that goat yogurt contains more potent PAF inhibitors than the cow or ewe yogurts and thus stronger *in vitro* anti-thrombotic properties. The *in vitro* anti-thrombotic properties of these yogurts could be attributed to the fact that during yogurt fermentation, bacteria such as *Streptococcus thermophilus* and *Lactobacillus bulgaricus* seem to augment the biosynthesis of lipids capable of inhibiting PAF activity ([@bib0010]; [@bib0005]).

The TLC polar lipid fractions 3 and 7 of both goat and ewe yogurts exhibited potent inhibitory activity against PAF-induced platelet aggregation ([Fig. 3](#fig0015){ref-type="fig"}) and were found to have similar R~f~ values to those of PC and CL. The concentrations of PC and CL in goat and ewe milk are considerably high ([@bib0020]). It could therefore be suggested that the strong *in vitro* anti-thrombotic activities found in goat and ewe yogurts could be due to biologically active lipids that are derivatives of PC and CL ([@bib0140], [@bib0090]).

The TLC polar lipid fraction 2 of both yogurt samples (goat and ewes), were found to contain lipid micro constituents inducing platelet aggregation ([Fig. 3](#fig0015){ref-type="fig"}), thus acting as PAF agonists. The presence of such PAF agonists (i.e. lipids with aggregatory activity) is beneficial because PAF agonists have been found to exhibit stronger *in vivo* antiatherogenic activity than PAF-inhibitors ([@bib0085]; [@bib0125]). This can be explained on the basis that these PAF agonists have a higher affinity than PAF to the PAF G-protein coupled receptors, hence they compete with PAF for its receptors; this biochemical competition results in antiatherogenic activity ([@bib0085]).

The results of the present study indicate that the lipid fractions (TPL or TLC polar lipid fractions) of all yogurt samples exhibited either aggregatory or inhibitory actions, suggesting that these lipid fractions are biologically active against PAF activity and consequently against thrombosis.

The results of the extracted TL of all yogurt samples reflected their reported fat concentration. The ewe's yogurt sample (7% fat) contained the highest TL levels. The TNL of all three yogurt samples were found to be the dominant lipid class whereas the TPL were present in lower levels ([Table 1](#tbl0005){ref-type="table"}).

SFAs were found to be higher in both the TPL and TNL of all yogurt samples followed by MUFAs and PUFAs, while the predominant fatty acids identified were palmitic (C16:0), oleic (C18:1), and stearic (C18:0) fatty acids ([Table 2](#tbl0010){ref-type="table"}a and b), which is in agreement with the literature ([@bib0105]; [@bib0115]). A number of metabolically valuable short and medium carbon chain FAs that are associated with the characteristic yogurt flavour and taste were identified. These include caproic (C6:0), caprylic (C8:0), capric (C10:0) and lauric (C12:0) fatty acids. The presence of these FAs was significantly higher in goat and ewe yogurts as opposed to cow yogurt ([Table 2](#tbl0010){ref-type="table"}a and b). The differences in fatty acid levels among these yogurt samples is species specific and can vary due to the different types of milk; the breed, age, stage of lactation and the nutrition of the animal ([@bib0115]; [@bib0075]; [@bib0100]).

The sensory evaluation of the yogurt samples demonstrated that the goat and ewe yogurts have been found to rate significantly higher for specific taste, aftertaste and texture attributes ([Fig. 4](#fig0020){ref-type="fig"}). Such organoleptic variations may be related to the observed differences in lipid content and fatty acid profile of the yogurt samples. The evaluation also identified that the ewe yogurt sample was the most palatable.

5. Conclusions {#sec0085}
==============

The *in vitro* anti-thrombotic activities, the fatty acid levels and the organoleptic properties of traditional Greek yogurts made using three different types of milk, were determined. The results highlight the biological properties of Greek yogurt lipids against thrombosis, suggesting a potential cardio-protective capacity for these yogurts. The fatty acid contents along with the organoleptic properties varied according to the type of milk used in the production of these yogurts. Our aggregometric data suggests that goat and ewe yogurt have stronger anti-thrombotic properties as opposed to cow yogurt. It is proposed that the activities evident in goat and ewe yogurts could be linked to lipids that are PC derivatives since they exhibit similar R~f~ values to PC. Further mechanistic studies are required in order to elucidate the structure of these potent anti-thrombotic yogurt derived lipids.
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[^1]: ^a,b^Different superscripts indicate significant differences among different yogurt samples within the same lipid class (cow vs. ewe yogurt, goat vs. ewe yogurt and cow vs. goat yogurt, respectively; *p* \< 0.05) when means are compared using a Fisher's LSD multiple comparison test.

[^2]: ^a,b,c^Different superscripts indicate significant differences among different yogurt samples within the same row (*p* \< 0.05) when means are compared using a Fisher's LSD multiple comparison test. SFA: saturated fatty acid; MUFA: monounsaturated fatty acid; PUFA: polyunsaturated fatty acid; ND: non detectable.

[^3]: ^a,b,c^Different superscripts indicate significant differences among different yogurt samples within the same row (*p* \< 0.05) when means are compared using a Fisher's LSD multiple comparison test. SFA: saturated fatty acid; MUFA: monounsaturated fatty acid; PUFA: polyunsaturated fatty acid; ND: non detectable.
